# Trial of ABI-007 in Previously Treated Patients With Metastatic Melanoma

> **NCT00093119** · PHASE2 · COMPLETED · sponsor: **Celgene** · enrollment: 75 (actual)

## Conditions studied

- Melanoma
- Metastases

## Interventions

- **DRUG:** ABI-007

## Key facts

- **NCT ID:** NCT00093119
- **Lead sponsor:** Celgene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** 2005-02
- **Final completion:** —
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2017-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00093119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00093119, "Trial of ABI-007 in Previously Treated Patients With Metastatic Melanoma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00093119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*